![]() dates back thousands of years (Abel 2013) but has been largely illegal worldwide for the best part of the last century. In this research, we examined commercially available, drug-type Cannabis strains using genetic methods to determine if the commonly referenced distinctions are supported and if samples with the same strain name are consistent when obtained from different facilities.Ĭultivation of Cannabis sativa L. ![]() As Cannabis legalization and consumption increases, the need to provide consumers with consistent products becomes more pressing. Despite more than 2000 named strains being available to consumers, questions about the consistency of commercially available strains have not been investigated through scientific methodologies. As Cannabis has become legal for medical and recreational consumption in many states, consumers have been exposed to a wave of novel Cannabis products with many distinctive names. Distinctive Cannabis varieties are ostracized from registration and therefore nearly impossible to verify. Unlike other plants, Cannabis sativa is excluded from regulation by the United States Department of Agriculture (USDA). The dataset used and/or analyzed during the current study are available from the corresponding author on reasonable request. Purchase receipts and original packaging of samples (when possible) were retained for reference. All purchased material was exhausted in genetic and chemical analyses (for another study). All specimens were purchased directly from dispensaries and samples were purchased from a customer perspective as-is, and, as such, voucher specimens are unavailable. Dispensaries did not provide any additional information on the flower purchased other than the standard information printed on the label (strain name and cannabinoid levels). Flower samples were purchased from dispensaries based on what was available on the shelf at the time of purchase. The locations of the dispensaries in this experiment were chosen randomly, therefore the experiment can be replicated without precise location information for the samples used here. The names for each dispensary are coded to protect the identity of businesses where genotypes may deviate from the norm. India’s daily rise in coronavirus cases and deaths retreated on Monday as the country logged over 3.66 lakh fresh coronavirus cases and 3,754 deaths, a slight dip from the daily 4 lakh and 4,000 India was seeing for the past few days.GUID: 2FFD9CF5-2E32-417A-A5AE-B835566B761E Data Availability Statement In late March, epidemiologists from dozens of countries said they believe the international community has “a year or less” before coronavirus variants spread widely enough to render a majority of first-generation vaccines ineffective-a nightmare scenario for the world and a major profit opportunity for the pharmaceutical industry. The WHO’s reclassification of B.1.617-which was previously labelled a “variant of interest”-came as experts and progressive campaigners continue to warn that people across the globe will remain in danger as long as public health measures are flouted and the coronavirus is allowed to spread uncontrolled among populations without access to vaccines. And so I think what we’re seeing is more transmissible.”įirst identified in India in December, the B.1.617 variant has since been detected in the United Kingdom, the US, Bangladesh, France, and other nations. “The pattern now is that one person in the family gets it, the whole family seems to get it,” Swaminathan told the Wall Street Journal on Monday. On Twitter, WHO chief scientist Soumya Swaminathan stressed that there is not yet enough information to determine whether the strain is able to evade vaccines or therapeutics and said her organization will be “updating variant data continuously.” Maria Van Kerkhove, the WHO’s technical lead for Covid-19, said during a press conference that while “we need much more information about this virus variant,” preliminary studies of the mutation have demonstrated “increased transmissibility.” The World Health Organization on Monday classified a coronavirus mutation first detected in India as a “variant of concern” for global health, warning that it appears to be more contagious than other strains.Įxperts believe the variant, formally known as B.1.617, could be a key driving force behind the devastating coronavirus surge in India, which has been reporting more than 400,000 new infections daily, with massive underreporting.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |